An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.
Rigolin GM, Formigaro L, Cavallari M, Quaglia FM, Lista E, Urso A, Guardalben E, Martinelli S, Saccenti E, Bassi C, Lupini L, Bardi MA, Volta E, Tammiso E, Melandri A, Negrini M, Cavazzini F, Cuneo A.
Rigolin GM, et al. Among authors: cuneo a.
Oncotarget. 2017 Apr 25;8(17):28008-28020. doi: 10.18632/oncotarget.15883.
Oncotarget. 2017.
PMID: 28427204
Free PMC article.